Growing community of inventors

Belle Meade, NJ, United States of America

Xian-Ping Lu

Average Co-Inventor Count = 4.86

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 34

Xian-Ping LuZhibin Li (5 patents)Xian-Ping LuSong Shan (5 patents)Xian-Ping LuZhiqiang Ning (5 patents)Xian-Ping LuTuo Deng (4 patents)Xian-Ping LuLeming Shi (4 patents)Xian-Ping LuZhi-Bin Li (3 patents)Xian-Ping LuZhi-Qiang Ning (3 patents)Xian-Ping LuBoyu Li (2 patents)Xian-Ping LuWeiming Hu (2 patents)Xian-Ping LuChenzhong Liao (2 patents)Xian-Ping LuZhende Liu (2 patents)Xian-Ping LuBaoshun Ma (2 patents)Xian-Ping LuAihua Xie (2 patents)Xian-Ping LuJindi Yu (1 patent)Xian-Ping LuXian-Ping Lu (8 patents)Zhibin LiZhibin Li (18 patents)Song ShanSong Shan (7 patents)Zhiqiang NingZhiqiang Ning (6 patents)Tuo DengTuo Deng (5 patents)Leming ShiLeming Shi (4 patents)Zhi-Bin LiZhi-Bin Li (3 patents)Zhi-Qiang NingZhi-Qiang Ning (3 patents)Boyu LiBoyu Li (2 patents)Weiming HuWeiming Hu (2 patents)Chenzhong LiaoChenzhong Liao (2 patents)Zhende LiuZhende Liu (2 patents)Baoshun MaBaoshun Ma (2 patents)Aihua XieAihua Xie (2 patents)Jindi YuJindi Yu (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shenzhen Chipscreen Biosciences, Ltd. (7 from 9 patents)

2. Tsinghua University (1 from 4,304 patents)

3. Chipscreen Biosciences, Ltd. (1 from 1 patent)


8 patents:

1. 8211901 - Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors

2. 8178577 - Tricyclic derivatives as potent and selective histone deacetylase inhibitors

3. 8158656 - 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors

4. 7863315 - 2-indolinone derivatives as selective histone deacetylase inhibitors

5. 7550490 - Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity

6. 7268157 - Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity

7. 7244751 - Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity

8. 7192970 - Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…